Skip to Main Content

News

TEMPORARY MARKETPLACE/COMMERCIAL WAIVERS EXPIRING FOR APPLICABLE COVID-19 TREATMENT AND TELEHEALTH SERVICES ON JUNE 1, 2021

Date: 06/01/21

As we continue to address the COVID-19 pandemic, we want to update you on important changes for our Marketplace/Commercial plans. Last year, we instituted temporary member cost share liability and prior authorization waivers for select services to ensure critical care could be quickly delivered to our members during a time of heightened need. On June 1, 2021, these temporary waivers will expire and our members’ Marketplace/Commercial plan benefits will be reinstated for the following services:

COVID-19 Treatment Related Services

  • COVID-19 treatment related services (those billed with a confirmed ICD-10 diagnosis code) will continue to be eligible for coverage at this time, in accordance with the member’s plan benefits.
  • Beginning June 1, 2021, prior authorization will be required for COVID-19 treatment related services, in accordance with CMS guidance and plan benefits.
  • Providers should also resume collecting Marketplace/Commercial member liability at the point of service for applicable treatment related services on June 1, 2021 onward.

All Telehealth Services

Prior authorization requirements and member cost share liability (copayments, coinsurance and/or deductible cost share amounts) will continue to be waived for COVID-19 testing, screening services and vaccinations at this time.

We are working in close partnership with state, local and federal authorities to serve and protect our members and communities during the COVID-19 pandemic, including ensuring that our providers have relevant and up-to-date information. We value your partnership during these unprecedented times.

This guidance is in response to the current COVID-19 pandemic and may be retired at a future date.